Table 2.
Time | IOP |
PR |
SBP |
DBP |
MAP |
||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
G1 | G2 | Δ | G1 | G2 | Δ | G1 | G2 | Δ | G1 | G2 | Δ | G1 | G2 | Δ | |
0 W | 23.40 ± 1.83 | 23.35 ± 1.55 | 0.06 | 81.23 ± 9.66 | 80.50 ± 10.29 | 0.73 | 129.69 ± 13.57 | 128.96 ± 14.67 | 0.73 | 82.92 ± 6.43 | 82.08 ± 6.50 | 0.85 | 98.51 ± 8.33 | 97.71 ± 8.92 | 0.80 |
2 W | 18.73 ± 1.73 | 18.60 ± 1.71 | 0.13 | 79.48 ± 7.36 | 74.79 ± 6.22 | 4.69** | 128.69 ± 12.58 | 125.65 ± 12.81 | 3.04 | 82.65 ± 7.51 | 81.73 ± 7.43 | 0.92 | 98.00 ± 8.12 | 96.37 ± 8.58 | 1.63 |
4 W | 18.10v1.36 | 17.73 ± 1.29 | 0.37 | 79.96 ± 7.19 | 74.15 ± 6.65 | 5.81** | 127.88 ± 11.69 | 126.73 ± 10.24 | 1.15 | 82.96 ± 8.20 | 81.58 ± 7.75 | 1.39 | 97.94 ± 8.36 | 96.63 ± 7.98 | 1.31 |
8 W | 17.64 ± 1.35 | 17.17 ± 1.12 | 0.47 | 79.83 ± 7.26 | 72.62 ± 6.32 | 7.21** | 127.08 ± 9.07 | 126.12 ± 11.95 | 0.96 | 82.92 ± 8.20 | 81.69 ± 7.24 | 1.23 | 97.64 ± 7.88 | 96.50 ± 8.13 | 1.14 |
12W | 16.85 ± 1.18 | 16.23 ± 1.29 | 0.62* | 80.37 ± 7.01 | 71.29 ± 5.08 | 9.08** | 127.81 ± 10.20 | 126.62 ± 11.59 | 1.19 | 83.54 ± 8.00 | 81.54 ± 7.38 | 2.00 | 98.29 ± 7.92 | 96.56 ± 8.27 | 1.73 |
DBP, diastolic blood pressure; FDC, fixed-dose combination; G1, travoprost monotherapy; G2, timolol/brinzolamide; IOP, intraocular pressure; MAP, mean arterial; pressure; PR, pulse rate; SBP, systolic blood pressure; W, week; Δ, mean difference in respective parameter between groups 1 and 2.
p < 0.05; **p < 0.001 mean difference in parameter between two groups.